These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 10155192)
1. Third- and fourth-generation implantable cardioverter defibrillators: current status and future development. Saksena S; Diaz ML; Varanasi S; Mathew P; Berg J; Krol RB; Kaushik RR J Interv Cardiol; 1994 Oct; 7(5):427-40. PubMed ID: 10155192 [TBL] [Abstract][Full Text] [Related]
2. [The implantable cardioverter/defibrillator (ICD). Developments up to the present time and future perspectives]. Brachmann J; Hilbel T; Schöls W; Beyer T; Schweizer M; Sterns L; Karolyi L; Melichercik J; Freigang KD; Kübler W Herz; 1994 Oct; 19(5):246-50. PubMed ID: 8001897 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants. Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705 [TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators. Bollmann A; Husser D; Cannom DS Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525 [TBL] [Abstract][Full Text] [Related]
5. Innovations in pulse generators and lead systems: balancing complexity with clinical benefit and long-term results. Saksena S; Krol RB; Kaushik RR Am Heart J; 1994 Apr; 127(4 Pt 2):1010-21. PubMed ID: 8160574 [TBL] [Abstract][Full Text] [Related]
6. Technologic advances in implantable cardioverter defibrillators. Swygman CA; Homoud MK; Link MS; Wang PJ; Estes NA Curr Opin Cardiol; 1999 Jan; 14(1):9-14. PubMed ID: 9932202 [TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter defibrillator therapy and the need for concomitant antiarrhythmic drugs. Singh S; Murawski MM J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):175-80. PubMed ID: 17875944 [TBL] [Abstract][Full Text] [Related]
8. Indications for dual-chamber (DDD) pacing in implantable cardioverter-defibrillator patients. Santini M; Ansalone G; Auriti A; Magris B; Pandozi C; Altamura G Am J Cardiol; 1996 Sep; 78(5A):116-8. PubMed ID: 8820847 [TBL] [Abstract][Full Text] [Related]
9. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation. Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943 [TBL] [Abstract][Full Text] [Related]
10. New technologies of internal defibrillation. Dosdall DJ; Ideker RE J Interv Card Electrophysiol; 2005 Aug; 13 Suppl 1():67-70. PubMed ID: 16133858 [TBL] [Abstract][Full Text] [Related]
11. Evidence rather than costs must guide use of the implantable cardioverter defibrillator. Delacretaz E; Schlaepfer J; Metzger J; Fromer M; Kappenberger L Am J Cardiol; 2000 Nov; 86(9A):52K-57K. PubMed ID: 11084101 [TBL] [Abstract][Full Text] [Related]
12. Comparison of clinical benefits and outcome in patients with programmable and nonprogrammable implantable cardioverter defibrillators. Mehta D; Saksena S; Krol RB; Makhija V Pacing Clin Electrophysiol; 1992 Sep; 15(9):1279-90. PubMed ID: 1383988 [TBL] [Abstract][Full Text] [Related]
13. Interactions of antiarrhythmic drugs with implantable defibrillator therapy for atrial and ventricular tachyarrhythmias. Krol RB; Saksena S; Prakash A Curr Cardiol Rep; 1999 Nov; 1(4):282-8. PubMed ID: 10980855 [TBL] [Abstract][Full Text] [Related]
15. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies. Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study. Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH; Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672 [TBL] [Abstract][Full Text] [Related]
17. Efficacy of long detection interval implantable cardioverter-defibrillator settings in secondary prevention population: data from the Avoid Delivering Therapies for Nonsustained Arrhythmias in ICD Patients III (ADVANCE III) trial. Kloppe A; Proclemer A; Arenal A; Lunati M; Martìnez Ferrer JB; Hersi A; Gulaj M; Wijffels MC; Santi E; Manotta L; Mangoni L; Gasparini M Circulation; 2014 Jul; 130(4):308-14. PubMed ID: 24838360 [TBL] [Abstract][Full Text] [Related]